Singapore Fling: AbbVie says a plant in Asia is just what it needs

Abbvie, which spun off from Abbott Laboratories since early last year, has picked Singapore for the location of a new manufacturing plant to handle ingredients for small-molecule and biologic drugs for oncology and immunology drug candidates. According to Abbvie, this move could help alleviate the problem of decrease in revenue when Humira, its best-selling drug, goes off patent in 2016, …

Download Presentation: Overcoming Impacts on FDA Regulations on Supply Chain Across Asia

At the last BioPharma Asia in 2013, ¬†Oliver Nicolai from Celgene gave a presentation entitled: Overcoming Impacts on FDA Regulations on Supply Chain Across Asia. Click here to download this presentation In this presentation, ¬†Oliver Nicolai touched on: Current commercial portfolio as well as significant potential of Celgene beyong 2015. Diversity and complexity of regional Asian countries. Factors that has …